A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474 - British Journal of Cancer
- ️Todd, I D H
- ️Tue Jun 01 1971
Abstract
An introductory clinical trial of the anti-oestrogenic agent IC146474 in late or recurrent carcinoma of the breast is described.
Forty-six patients have been treated, of whom 10 have shown a good response. This is of the same order as that seen with oestrogens and androgens.
The particular advantage of this drug is the low incidence of troublesome side effects.
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Authors
- M P Cole
- C T A Jones
- I D H Todd
Rights and permissions
About this article
Cite this article
Cole, M., Jones, C. & Todd, I. A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474. Br J Cancer 25, 270–275 (1971). https://doi.org/10.1038/bjc.1971.33
Issue Date: 01 June 1971
DOI: https://doi.org/10.1038/bjc.1971.33